EGFR and non-small cell lung carcinoma: Strongly PD-L1 positive EGFR mutant NSCLC was associated with inferior prognosis (HR 7.05, 95% CI 1.62–30.61, p = 0.002), than EGFR wild-type NSCLC although these numbers were limited.